跳转至内容
Merck
CN

17-500M

Catch and Release v2.0 可逆免疫沉淀系统

别名:

免疫沉淀试剂盒, 捕获与释放系统

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

UNSPSC Code:
12161503
NACRES:
NB.22
eCl@ss:
32161000
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


species reactivity (predicted by homology)

all

Quality Level

manufacturer/tradename

Catch And Release, Upstate®

technique(s)

activity assay: suitable (IP-kinase), immunoprecipitation (IP): suitable, western blot: suitable

shipped in

wet ice

General description

特征&优点:
可重现:消除了通常导致减少/丢失样品的抽吸步骤
方便性:旋转柱形式极大地简化了样品处理
可逆:抗原:抗体复合物以天然或变性形式简单洗脱:



用途:
该试剂盒可通过使用旋转柱进行快速且可重现的免疫沉淀(IP)。 该系统比常规IP′具有更高的重现性,后者在不破坏琼脂糖床的情况下洗涤蛋白A/G琼脂糖方面存在问题。 抗体/抗原复合物在Catch and Release中的结合是可逆的,并且免疫复合物的洗脱可以用天然或变性缓冲液进行。 该系统已通过兔,小鼠,绵羊和山羊抗体成功测试。 使用人IgG1-4的IP应该是合适的。 本试剂盒不建议使用鸡抗体或人IgA、IgD、IgE或IgM进行IP。 使用前请阅读随附的产品手册。

Application

Catch and Release v2.0不应与含有6-His标签的蛋白质一起使用。

Packaging

50次免疫沉淀

Preparation Note

全部组分应在4°C下储存,但Catch and Release捕获管除外,后者在室温下储存。 组件自装运之日起6个月内保持稳定。

Analysis Note

通过免疫沉淀进行了常规评估。

Other Notes

Catch and Release 清洗缓冲液,10X(目录号20-210)

Catch and Release 非变性洗脱缓冲液,4X(目录号20-209)

Catch and Release 变性洗脱缓冲液,1X(目录号20-284)

20-285

20-216

Catch and Release 捕获管

Legal Information

UPSTATE is a registered trademark of Merck KGaA, Darmstadt, Germany


signalword

Danger

存储类别

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

Hazard Classifications

Aquatic Acute 1 - Aquatic Chronic 2 - ED ENV 1 - Eye Dam. 1 - Repr. 1B - Skin Corr. 1C



分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Nan Zhang et al.
Diabetes, 53(4), 963-970 (2004-03-30)
Successful islet transplantation depends on the infusion of sufficiently large quantities of islets, of which only approximately 30% become stably engrafted. Rapid and adequate revascularization of transplanted islets is important for islet survival and function. Delayed and insufficient revascularization can
Neonatal hypoxia-ischemia differentially upregulates MAGUKs and associated proteins in PSD-93-deficient mouse brain
Jiang, X., et al
Stroke, 34, 2958-2963 (2003)
Wanxia He et al.
Journal of virology, 77(19), 10566-10574 (2003-09-13)
Addition of human papillomavirus (HPV) E7 CDK2/cyclin A or CDK2/cyclin E, purified from either insect cells or bacteria, dramatically upregulates histone H1 kinase activity. Activation is substrate specific, with a smaller effect noted for retinoblastoma protein (Rb). The CDK2 stimulatory



全球贸易项目编号

货号GTIN
17-50004053252323119
17-500A04053252744976